Mometasone Furoate Monohydrate Aurobindo

Mometasone furoate, the active ingredient in Mometasone Furoate Monohydrate Aurobindo, is a corticosteroid presented as a nasal spray for nasal use. It treats allergic rhinitis, including seasonal and perennial forms, in adults and children.

GNH USA supplies Mometasone Furoate Monohydrate Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone furoate is a topical corticosteroid indicated for inflammatory conditions of the nasal mucosa.

Allergic rhinitis: reduces nasal congestion, itching, and sneezing. Seasonal allergic rhinitis: provides rapid relief of seasonal allergy symptoms. Perennial allergic rhinitis: offers sustained control of year‑round nasal inflammation.

Mometasone furoate nasal spray may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning - Headache - Sneezing or mild nosebleeds - Altered taste or throat irritation

Serious or Rare Side Effects: - Nasal septal perforation - Severe allergic reaction (anaphylaxis) - Adrenal suppression with prolonged use

Before using Mometasone furoate nasal spray, consider the following safety measures.

Pregnancy: consult a healthcare provider; safety not established. Breastfeeding: use with caution; limited data available. Use in children: follow pediatric guidance and monitor growth. Avoid concomitant nasal decongestants to reduce irritation. Do not exceed the recommended duration without medical advice. Store at room temperature: keep in the original container, protect from moisture and heat.

Mometasone furoate may interact with other medicines; monitor as indicated.

Major Interactions (Avoid): - Systemic corticosteroids: increased risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors: may raise local drug exposure.

Moderate Interactions (Monitor Closely): - Antihistamines: may enhance sedation, though effect is minimal. - Nasal antibiotics: could increase local irritation. - Live nasal vaccines: efficacy may be reduced.